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Program evaluation methods in econometrics have become increasingly sophisticated. In this study, we
assess and compare the bias of estimators of three common parameters — the average treatment eﬀect
(ATE), the average treatment eﬀect on the treated (ATT), and the average treated on the untreated
(ATU) — that require the unconfoundedness assumption when, in fact, unconfoundedness fails.T h u s ,
our study represents an extension to the analysis ﬁrst put forth in Black and Smith (2004) for the ATT.
In that paper, the authors show that under certain conditions, estimators of the ATT that require the
unconfoundedness assumption to be unbiased, but are biased when this assumption fails to hold, obtain a
minimum bias when the sample is restricted to observations with a probability of treatment, conditional
on covariates, close to one-half.
In this paper, we have four speciﬁc objectives. First, we assess the bias of so-called selection on
observables estimators of the ATE and ATU under the same assumptions as in Black and Smith (2004).
Second, we provide a set of assumptions — frequently invoked in applied settings — that enable us to rank
the magnitude of the bias of estimators across the three parameters. Third, we propose a new estimation
technique for researchers seeking to minimize the bias of selection on observables estimators of the ATE
when unconfoundedness fails to hold. We then compare the ﬁnite sample performance of our proposed
method by Monte Carlo methods. Finally, we compare the performance of our estimator to those currently
utilized in the literature to assess the eﬀects of participation in the national School Breakfast Program
(SBP) on childhood obesity.
Our results should be of interest to the growing number of applied researchers relying on estimators
from the program evaluation literature, especially when the researcher is concerned that the unconfound-
edness assumption is problematic but a valid exclusion restriction is unavailable. Speciﬁcally, we oﬀer two
recommendations to applied researchers. First and foremost, researchers ought to be skeptical of estimates
obtained using parametric methods unless the correct functional form is known. Second, our new estima-
tion technique represents an improvement over the performance of the semiparametric estimator of the
ATE proposed in Hirano and Imbens (2001). In fact, our bias minimizing approach yields a ﬁnite sample
improvement over Hirano and Imbens (2001) even when the underlying assumptions of their estimator are
valid in the population. However, our estimation technique is particularly useful when there is selection
on unobservables. While the fact that our estimator is preferable even when unconfoundedness holds may
appear striking at ﬁrst glance, it is consistent with other results in the literature. In particular, Hirano
et al. (2003) ﬁnd that using an estimated propensity score is preferable even when the true propensity
score is known, and Millimet and Tchernis (2007) ﬁnd that over-ﬁtting the propensity score equation is
1preferable to using the true functional form.
The remainder of the paper is organized as follow. Section 2 begins by providing a quick overview of
the potential outcomes and corresponding treatment eﬀects framework. Next, it contains our analysis of
the bias of each of the three parameters considered herein under certain assumptions. Finally, we propose
a new estimation method in Section 2. Our estimator attempts to minimize the bias of estimators of the
ATE that rely on unconfoundedness when, in fact, this assumption is false. Section 3 presents a Monte
Carlo study comparing the performance of our proposed estimator to other estimators commonplace in the
literature. Section 4 contains the application to school nutrition programs. Section 5 concludes.
2 The Evaluation Problem
2.1 Setup
Consider a random sample of N individuals from a large population indexed by i =1 ,...,N.U t i l i z i n g
the potential outcomes framework (see, e.g., Neyman 1923; Fisher 1935; Roy 1951; Rubin 1974), let Yi(T)
denote the potential outcome of individual i under treatment T, T ∈ T . Here, we consider only the case of
binary treatments: T = {0,1}. The causal eﬀect of the treatment (T =1 )r e l a t i v et ot h ec o n t r o l( T =0 )
is deﬁned as the diﬀerence between the corresponding potential outcomes. Formally,
τi = Yi(1) − Yi(0). (1)
In the evaluation literature, several population parameters are of potential interest. The most commonly
used include the ATE, the ATT, and the ATU. These are deﬁned as
τATE = E[τi]=E[Yi(1) − Yi(0)] (2)
τATT = E[τi|T =1 ]=E[Yi(1) − Yi(0)|T =1 ] (3)
τATU = E[τi|T =0 ]=E[Yi(1) − Yi(0)|T =0 ] . (4)
In general, the parameters in (2) — (4) may vary with a vector covariates, X.A sar e s u l t ,e a c ho ft h e
parameters may be deﬁned conditional on a particular value of X as follows:
τATE[X]=E[τi|X]=E[Yi(1) − Yi(0)|X] (5)
τATT[X]=E[τi|X,T =1 ]=E[Yi(1) − Yi(0)|X,T =1 ] (6)
τATU[X]=E[τi|X,T =0 ]=E[Yi(1) − Yi(0)|X,T =0 ] . (7)
2The parameters in (2) — (4) are obtained by taking the expectation of the corresponding parameter in (5)
— (7) over the distribution of X in the relevant population (the unconditional distribution of X for the
ATE, and distribution of X condition on T =1and T =0for the ATT and ATU, respectively).
For each individual, we observe the triple {Yi,T i,X i},w h e r eYi is the observed outcome, Ti is a binary
indicator of the treatment received, and Xi is a vector of covariates. The only requirement of the covariates
included in Xi is that they are pre-determined (that is, they are unaﬀected by Ti) and do not perfectly
predict treatment assignment. The relationship between the potential and observed outcomes is given by
Yi = TiYi(1) + (1 − Ti)Yi(0) (8)
which makes clear that only one potential outcome is observed for any individual. As such, estimating τ
is not trivial as there is an inherent missing data problem; some assumptions are required to proceed.
One such assumption is unconfoundedness or selection on observables (Rubin 1974; Heckman and
Robb 1985). Under this assumption, treatment assignment is said to be independent of potential outcomes
conditional on the set of covariates, X. As a result, selection into treatment is random conditional on X
and the average eﬀect of the treatment can be obtained by comparing outcomes of individuals in diﬀerent
treatment states with identical values of the covariates. To solve the dimensionality problem that is
likely to arise if X is a lengthy vector, Rosenbaum and Rubin (1983) propose using the propensity score,
P(Xi)=P r ( Ti =1 |Xi), instead of X as the conditioning variable.
2.2 Bias When Unconfoundedness Fails
Given knowledge of the propensity score, or an estimate thereof, and suﬃcient overlap between the distri-
butions of the propensity score across the T =1and T =0groups (typically referred to as the common
support condition; see Dehejia and Wahba (1999) or Smith and Todd (2005)), the parameters discussed
above can be estimated in a number of ways under the unconfoundedness assumption (D’Agostino (1998)
and Imbens (2004) oﬀer summaries). Regardless of which such technique is employed, each will be biased
if the unconfoundedness assumption fails to hold.
Black and Smith (2004) consider the bias when estimating the ATT under unconfoundedness and the
3assumption is incorrect. The bias of the ATT at some value of the propensity score, P(X),i sg i v e nb y
BATT[P(X)] = b τATT[P(X)] − τATT[P(X)]
= {E[Y (1)|T =1 ,P(X)] − E[Y (0)|T =0 ,P(X)]}
−{E[Y (1)|T =1 ,P(X)] − E[Y (0)|T =1 ,P(X)]}
= E[Y (0)|T =1 ,P(X)] − E[Y (0)|T =0 ,P(X)] (9)
where b τATT refers some propensity score based estimator of the ATT (e.g., propensity score matching or
inverse propensity score weighting).
To better understand the behavior of the bias, Black and Smith (2004) make the following two assump-
tions:
(A1) Potential outcomes and latent treatment assignment are additively separable in observables and
unobservables
Y (0) = g0(X)+ε0
Y (1) = g1(X)+ε1





1 if T∗ > 0
0 otherwise














Given A1 and A2, (9) simpliﬁes to





where φ(•) and Φ(•) are the standard normal density and cumulative density function, respectively. As
noted in Black and Smith (2004), BATT[P(X)] is minimized when h(X)=0 , which implies that P(X)=
40.5. Thus, the authors recommend that researchers estimate τATT using the ‘thick support’ region of the
propensity score (e.g., P(X) ∈ (0.33,0.67)).
Prior to continuing, it is important to note that if the ATT varies with X (and, hence, P(X)), then
using only observations on the thick support estimates a diﬀerent parameter than the population ATT given
in (3). Indeed, the procedure suggested in Black and Smith (2004) accomplishes the following. It searches
over the parameters deﬁn e di n( 6 )t oﬁnd the value of P(X) for which the τATT[P(X)] can be estimated
with the least bias. This subtle, or perhaps not so subtle, point is very intriguing. Stated diﬀerently,
when unconfoundedness fails, τATT, the population ATT, cannot be estimated in an unbiased manner
using estimators that rely on this assumption. Rather than invoking diﬀerent assumptions to identify the
population ATT (e.g., those utilized by selection on unobservables estimators), the Black and Smith (2004)
approach identiﬁes the parameter that can be estimated with the smallest bias under unconfoundedness.
Whether or not the parameter being estimated with the least bias, e τATT = E[E[τi|P(X),T =1 ] ] ,w h e r e
the outer expectation is over X|0.33 <P(X) < 0.67 and T =1 , is an interesting economic parameter is a
diﬀerent question. The key point, however, is that when restricting the estimation sample to observations
with propensity scores contained in a subset of the unit interval, the parameter being estimated will diﬀer
from the population ATT unless the treatment eﬀect does not vary with X (i.e., E[τi|P(X),T =1 ]=
E[τi|T =1 ] ).
With this point in mind, we now consider the bias for the ATE and the ATU since the ATT is not the
only parameter of interest in applied settings. For the ATU, it is trivial to show that





which is also minimized when h(X)=0 ,o rP(X)=0 .5. However, it is useful to note that
BATU[P(X)] = E[δ + ε0|T =1 ,P(X)] − E[δ + ε0|T =0 ,P(X)]
= BATT[P(X)] + E[δ|T =1 ,P(X)] − E[δ|T =0 ,P(X)]
where δ = ε1 − ε0 is the unobserved, individual-speciﬁc gain from treatment. Thus, the magnitude of the
bias of the ATU may either be larger or smaller than the corresponding bias of the ATT. If we add the
following assumption:
5(A3) Non-negative selection into the treatment on individual-speciﬁc, unobserved gains
E[δ|T =1 ,P(X)] > E[δ|T =0 ,P(X)]
then BATU[P(X)] > BATT[P(X)] for all P(X).1
Now consider the ATE. Utilizing the fact that τATE[P(X)] = P(X)τATT[P(X)]+[1−P(X)]τATU[P(X)],


















Equation (12) leads to three salient points. First, the bias of the ATE is minimized when h(X)=0
only in the case where ρδu =0(i.e., no selection on unobserved, individual-speciﬁc gains to treatment).
Second, under A1 — A3, BATU[P(X)] > BATE[P(X)] > BATT[P(X)]. Third, the value of P(X) that
minimizes the bias of the ATE is not ﬁxed; rather, it depends on the signs and magnitudes of ρ0uσ0 and
ρδuσδ. Simulations (see Figures 1 and 2) reveal that BATE[P(X)] displays the following properties:
(i) if ρ0uσ0 =0 ,t h e nlimP(X)−→1 BATE[P(X)] = 0
(ii) if ρ0uσ0 = −ρδuσδ,t h e nlimP(X)−→0 BATE[P(X)] = 0
(iii) if ρ0uσ0 > 0,t h e nP∗ =a r gm i nBATE[P(X)] is
(a) strictly greater than 0.5
(b) decreasing in ρ0uσ0 (holding ρδuσδ ﬁxed)
(c) increasing in ρδuσδ (holding ρ0uσ0 ﬁxed)
(iv) if ρ0uσ0 < 0,t h e nP∗ =a r gm i nBATE[P(X)] is
(a) above or below 0.5, but monotonically increasing, for ρ0uσ0 ∈ (−ρδuσδ,0)
(b) strictly less than 0.5, but decreasing in ρ0uσ0 (holding ρδuσδ ﬁxed) for ρ0uσ0 < −ρδuσδ
(c) decreasing in ρδuσδ (holding ρ0uσ0 ﬁxed) for ρ0uσ0 < −ρδuσδ.
where P∗ is the value of the propensity score that minimizes the bias in (12). We refer to P∗ as the bias
minimizing propensity score (BMPS). See Figure 3 for a complete characterization of P∗.
1See Heckman and Vytlacil (2005) for further discussion on this assumption.
62.3 Estimation
To assess the bias of selection on observables estimators of the ATE when unconfoundedness fails, we
utilize the normalized inverse probability weighted estimator of Hirano and Imbens (2001). Horvitz and





















1 − ˆ P(Xi)
#
. (14)
The estimator in (14) is the unnormalized estimator as the weights do not necessarily sum to unity. To
circumvent this issue, Hirano and Imbens (2001) propose an alternative estimator, referred to as the























1 − ˆ P(Xi)
#
. (15)
Millimet and Tchernis (2007) provide evidence of the superiority of the normalized estimator in practical
settings.
Under unconfoundedness, the normalized estimator in (15) provides an unbiased estimate of τATE.
When this assumption fails, the bias is given (12). To minimize the bias, we propose to estimate (15) using
only observations with a propensity score in a neighborhood around the BMPS, P∗. Formally, we propose



























Ω = {i| ˆ P(Xi) ∈ C(P∗)},
and C(P) denotes a neighborhood around P. In the estimation below, we deﬁne C(P∗) as
C(P∗)={ ˆ P(Xi)| ˆ P(Xi) ∈ (P,P)},
where P =m a x {0.02,P∗ − αθ}, P =m i n {0.98,P∗ + αθ},a n dαθ > 0 is the smallest value such that at
7least θ percent of both the treatment and control groups are contained in Ω. In the exercises below, we set
θ =0 .05, 0.10,a n d0.25. For example, if θ =0 .05,w eﬁnd the smallest value, α0.05, such that 5% of the
treatment group and 5% of the control group have a propensity score in the interval (P,P). Thus, smaller
values of θ should reduce the bias at the expense of higher variance. Note, we trim observations with
propensity scores above (below) 0.98 (0.02), regardless of the value of θ, to prevent any single observations
from receiving too large of a weight.
As deﬁned above, the set Ω is unknown since, in general, P∗ is unknown. To estimate the set Ω,w e
propose to estimate P∗ assuming A1, A2, and functional forms for g0(X), g1(X),a n dh(X) using the
















where φ(·)/Φ(·) is the inverse Mills’ ratio, η is a well-behaved error term, and
βλ0 = ρ0uσ0 (18)
βλ1 = ρ0uσ0 + ρδuσδ.
Thus, OLS estimation of (17) after replacing γ with an estimate obtained from a ﬁrst-stage probit model
yields consistent estimates of ρ0uσ0 and ρδuσδ. With these estimates, one can use (12) to obtain an estimate
of P∗.2
Our proposed estimator immediately raises a question: If one is willing to maintain the assumptions
underlying the BVN selection model in (17), why not just use the OLS estimates of (17) to estimate the
ATE? Perhaps one should. If the assumptions underlying the BVN selection model are valid, then one
should; the ATE is estimated by
ˆ τBVN = X
³
b β1 − b β0
´
. (19)
However, if these assumptions fail, then perhaps the estimator in (15) or (16) will perform better in practice.
2To estimate P
∗, we conduct a grid search over 1,000 equally-spaced values of h(·) from -5 to 5. If P
∗ is above 0.98, we
truncate it to 0.98; if P
∗ is below 0.02, we truncate it to 0.02.
8To better understand the ﬁnite sample performance of these estimators, we now turn to our Monte Carlo
study.
3 Monte Carlo Study
3.1 Setup
To assess the performance of the various estimators, we use ﬁve experimental designs. However, for each
experimental design, we use two data-generating processes (DGPs): (i) a constant treatment eﬀect setup
(i.e., τi = τ for all i), and (ii) a heterogeneous treatment eﬀect setup, where the heterogeneity is due to
unobserved, individual-speciﬁc gains to treatment (i.e., τi varies across i, but this variation is unrelated to
variation in observables, X). Thus, we are focusing on cases where all of the estimators being compared
are estimating the same underlying parameter, τATE = E[τi].




h(X)=x1 + x2 − 0.5(x2
1 − x2
2)+x1x2





1 if T∗ > 0
0 otherwise
for 1000 observations. Furthermore, in the constant treatment eﬀect setup:
Y (0) = g0(X)+ε0 = h(X)+ε0
Y (1) = g1(X)+ε0 =1+h(X)+ε0
which implies that τi =1for all i and τATE = E[τi]=1 . In the heterogeneous treatment eﬀect setup:
Y (0) = g0(X)+ε0 = h(X)+ε0
Y (1) = g1(X)+ε1 =1+h(X)+ε1
which implies that τi =1+ε1i − ε0i =1+δi and τATE = E[τi]=1(assuming E[δi]=0 , as discussed
9below).
Our ﬁve experimental designs are:
























In addition, in both cases, the correct functional forms of the ﬁrst-stage propensity score equation
and the second-stage outcome equation in (17) are assumed to be known.
2. All assumptions of the BVN selection model are correct except the second-stage outcome equation in
(17) is mis-speciﬁed. Speciﬁcally, the error distributions are identical to experiment #1, and the
ﬁrst-stage propensity score equation is assumed to be known, but x2
1, x2
2,a n dx1x2 are omitted from
the set of covariates included in (17).
3. All assumptions of the BVN selection model are correct except the ﬁrst-stage propensity score equation
and the second-stage outcome equation in (17) are mis-speciﬁed. Speciﬁcally, the error distributions
are identical to experiment #1, but x2
1, x2
2,a n dx1x2 are omitted from the set of covariates included
in both the ﬁrst-stage propensity score equation and (17).
4. All assumptions of the BVN selection model are correct except the errors are uniformly distributed.























In both cases, the correct functional forms of the ﬁrst-stage propensity score equation and the second-
stage outcome equation in (17) are assumed to be known.
5. All assumptions of the BVN selection model are correct except the errors are uniformly distributed
and the second-stage outcome equation in (17) is mis-speciﬁed. Speciﬁcally, the error distributions
are identical to experiment #4, and the ﬁrst-stage propensity score equation is assumed to be known,
but x2
1, x2
2,a n dx1x2 are omitted from the set of covariates included in (17).
Each experiment is conducted for several combinations of true values for ρ0uσ0 and ρδuσδ, including
the case where unconfoundedness holds. To assess the performance of the estimators, we report the mean
estimates of ρ0uσ0 and ρδuσδ, and the mean values of αθ, θ =0 .05, 0.10,a n d0.25. In addition, we report
the mean bias, the mean absolute error (MAE), and the mean squared error (MSE) for each estimator.
Note, for the constant treatment eﬀect setup, we estimate ρ0u and (19) using













where βλ = ρ0uσ0.
3.2 Results
The results for the ﬁve experimental designs are presented in Tables 1-5. Table 1 is the benchmark case;
the DGPs satisfy the assumptions of the BVN model, and the correct functional forms are utilized in the
ﬁrst-stage probit model for the propensity score and second-stage equation for the outcome. As mentioned
above, even absent an exclusion restriction in the ﬁrst-stage, we expect the BVN estimator to outperform
the other estimators given the eﬃciency gain from imposing restrictions that hold in the DGP.
11The results in Table 1 conﬁrm our expectations. In all cases except one, b τBVN has the smallest
bias. In addition, b τBVN has the smallest MAE and MSE in all cases, including the two cases where
unconfoundedness holds (ρ0uσ0 =0in the constant treatment eﬀect setup and ρ0uσ0 = ρδuσδ =0in
the heterogeneous treatment eﬀect setup). However, if one restricts attention to only the estimators that
require unconfoundedness for unbiasedness, our estimator, b τMB, outperforms the Hirano and Imbens (2001)
estimator, b τHI, in all cases when there is at least some selection on unobservables. Moreover, even when
selection on unobservables holds, our minimum biased estimator still outperforms b τHI for at least some
value of θ.
Among the minimum biased estimators, utilizing a smaller value of θ is preferable in terms of bias,
MAE, and MSE in the majority of cases when selection on unobservables is ‘suﬃciently’ large. However, a
larger value of θ is preferable in terms of MSE under unconfoundedness or when selection on unobservables
is ‘suﬃciently’ weak. For example, b τMB,0.05 or b τMB,0.10 yields the smallest bias, MAE, and MSE when
ρ0uσ0 > 0 and ρδuσδ > 0 in the heterogeneous treatment eﬀect setup; b τMB,0.05 or b τMB,0.10 yields the
smallest bias and MAE in the constant treatment eﬀect setup when ρ0uσ0 > 0.5 (but a higher MSE
when ρ0uσ0 =0 .25). Conversely, when unconfoundedness holds in either the heterogeneous or constant
treatment eﬀect setup, b τMB,0.25 yields the smallest MAE and MSE. Thus, when using weighting estimators
of the ATE, our minimum biased estimator is preferable on both bias and eﬃciency grounds relative to
Hirano and Imbens (2001) estimator, and the value of θ should be decreasing in the amount of selection
on unobservables suspected by the researcher.
Prior to continuing, it is worth emphasizing the point that the ‘optimal’ θ does not go to unity when
unconfoundedness holds. Thus, even when selection on observables holds in the population, ﬁnite sample
performance can be improved by removing any within sample correlation among the errors. This ﬁnding
is consistent with the results in Hirano et al. (2003), who ﬁnd that using an estimated propensity score
is preferable even when the true propensity score is known, and Millimet and Tchernis (2007), who show
that over-ﬁtting the propensity score equation is preferable to using the true functional form.
Table 2 provides the results from our second experimental design. Recall, the only deviation from the
design employed in Table 1 is that now the second-stage outcome equation in (17) and (20) is mis-speciﬁed;
we omit x2
1, x2
2,a n dx1x2 from the estimation. Thus, this corresponds to a situation where a researcher
incorrectly assumes a linear functional form in the second-stage.
Note two important details before turning to the results. First, the ﬁrst-stage probit model for the
propensity score is speciﬁed correctly. As a result, the model now contains three exclusion restrictions in
the probit equation, although they are not ‘valid’ exclusion restrictions since x2
1, x2
2,a n dx1x2 also have a
direct eﬀect on y. Second, because the propensity score equation is correctly speciﬁed, the performance of
12b τHI will be identical to that in Table 1; the diﬀerence in the experimental designs does not impact this
estimator. However, our estimator, b τMB,i sa ﬀected because the estimate of the BMPS, P∗, depends on
the estimates from the second-stage equation in (17) and (20). Thus, whether our estimator continues to
outperform b τHI is not clear a priori.
In terms of the results, three ﬁndings stand out. First, b τBVN does signiﬁcantly worse than any of
the other estimators in terms of bias, MAE, and MSE. Speciﬁcally, the MAE ranges from roughly ten
to 100 times as large; the MSE is 100 to 1000 times as large. Second, our estimator, b τMB, continues to
outperform b τHI in all cases. Thus, our estimator continuous to constitute an improvement upon b τHI even
when unconfoundedness holds (for at least some value(s) of θ).
Finally, while not universal, a smaller value θ is generally preferable in terms of bias, MAE, and
MSE as the degree of selection of unobservables increases; b τMB,0.25 yields the smallest MAE only when
unconfoundedness holds or when ρ0uσ0 =0and ρδuσδ =0 .15 a n dt h es m a l l e s tM S Eo n l yi nt w oo t h e r
cases where the extent of selection of unobservables is not ‘suﬃciently’ large (the constant treatment eﬀect
setup with ρ0uσ0 =0 .25 and the heterogeneous treatment eﬀect setup with ρ0uσ0 =0 .15 and ρδuσδ =0 ).
Thus, as the extent of selection on unobservables gets stronger, one wants to restrict the estimation sample
to observations closer to the estimated BMPS, P∗.
Table 3 presents the results for the same DGPs as in the two preceding tables except now both the
ﬁrst-stage probit model and the second-stage outcome equation are mis-speciﬁed. Speciﬁcally, both are
estimated incorrectly assuming a linear functional form; x2
1, x2
2,a n dx1x2 are omitted. Unfortunately,
this might be the most relevant case for applied researchers. The results are easily summarizable. First,
none of the estimators perform well, but b τBVN does signiﬁcantly worse than the other estimators. Second,
b τMB,0.05 yields the lowest bias, MAE, and MSE in all cases. Relative to b τMB,0.05,t h eM A E( M S E )o fb τHI
is roughly two to three (four to ten) times larger.
The results in Table 3 should have been expected given the prior results in Table 2. The common
omitted covariates from both the ﬁrst- and second-stage equations generate a strong correlation between
the error terms in the potential outcome equation in the untreated state and treatment assignment equation
even if ρ0uσ0 =0in the population. Thus, given the mis-speciﬁcation, all cases in experimental design
correspond to the case of ‘suﬃciently’ strong selection on unobservables. In this case, as we saw in Table
2, θ =0 .05 is preferable.
Table 4 displays the results from the next experimental design. Here, we revert back to the benchmark
case in that we assume the correct functional form for both the ﬁrst-stage propensity score model and
second-stage outcome equation are known. However, the error terms are no longer normally distributed;
rather, they are drawn from a correlated multivariate uniform distribution. The results are interesting.
13First, b τBVN clearly dominates the other estimators, even when unconfoundedness holds. Presumably this
is because the (incorrect) normality assumption invoked in the ﬁrst-stage probit model is a reasonable
approximation.3 Second, our estimator continues to outperform b τHI when unconfoundedness holds (for
θ =0 .10 or 0.25), and when it does not (for all values of θ).
Third, as in the previous cases, within our estimator a smaller value θ is preferable in terms of MAE and
MSE as the degree of selection of unobservables increases. For instance, b τMB,0.25 and b τMB,0.10 yield the
smallest MAE and MSE (within our estimator) in the constant treatment eﬀect setup when unconfounded-
ness holds, but b τMB,0.10 is preferable in the other two cases. In the heterogeneous treatment eﬀect setup,
b τMB,0.25 yields the smallest MAE and MSE (within our estimator) when ρ0uσ0 =0and ρδuσδ =0or 0.25,
or when ρ0uσ0 =0 .15 and ρδuσδ =0 . b τMB,0.05 yields the smallest MAE and MSE (within our estimator)
when ρ0uσ0 =0 .30 and ρδuσδ =0 .50. Thus, there is essentially a negative, monotonic relationship between
the ‘optimal’ θ and the extent of selection on unobservables. Speciﬁcally, θ =0 .25 minimizes the MAE and
MSE (relative to the other values of θ employed) when unconfoundedness holds; θ =0 .05 minimizes the
MAE and MSE when selection on unobservables is ‘suﬃciently’ strong; θ =0 .10 does best when selection
on unobservables is present, but a bit ‘weaker.’
Our ﬁnal experimental design combines the error mis-speciﬁcation from the previous DGP, with the
functional form mis-speciﬁcation of the second-stage outcome equation analyzed in the second experiment.
The results are provided in Table 5. Again, several interesting ﬁndings emerge. First, as in Table 2, b τBVN
performs signiﬁcantly worse than the other estimators. Thus, while error mis-speciﬁcation (of the type
analyzed here) is not particularly problematic for the BVN estimator, mis-speciﬁcation of the outcome
equation is very troublesome. Second, our estimator continues to outperform b τHI when unconfoundedness
holds (for θ =0 .10 and 0.25), and when it does not (for all values of θ). In the heterogeneous treatment
eﬀect setup under unconfoundedness, the MAE and MSE of b τHI is 1.3 and 1.5 times higher, respectively,
than of b τMB,0.25. Finally, there continues to exist a negative, monotonic relationship between the ‘optimal’
θ and the extent of selection on unobservables as in Table 4.
3.3 Discussion
The simulation results presented, while clearly not exhausting all situations applied researchers confront,
suggest a number of guidelines that researchers ought to ﬁnd useful. First and foremost, researchers ought
to be very wary when using the BVN estimator. Aside from the reliance on distributional assumptions,
our study indicates that utilizing the proper functional form in the outcome equation is crucial. It is
so crucial that we obtain drastically better estimates utilizing semiparametric estimators that require
3In test runs using our DGP, we do, however, reject normality of u using the test developed in Royston (1991).
14unconfoundedness even when unconfoundedness does not hold.
Second, regardless of whether the outcome equation used in the BVN model is correctly speciﬁed,
restricting the sample to only those observations whose propensity score lies in a certain region of the unit
interval, where the restricted region is determined utilizing estimates obtained from the estimation of the
BVN model, improves the performance of the semiparametric estimator proposed in Hirano and Imbens
(2001). Thus, our bias minimizing approach yields a ﬁnite sample improvement over Hirano and Imbens
(2001) even when the underlying assumptions of that estimator are valid in the population.
Finally, how ‘tight’ to restrict the sample used in the estimation depends on the underlying correlation
structure of the unobservables in the model. Among the cases considered here, the ‘optimal’ restriction
becomes tighter as the degree of selection on unobservables increases. When unconfoundedness holds,
utilizing θ =0 .25 achieves the best performance of the values considered here. However, when selection on
unobservables is present, but is ‘modest’ in some sense, utilizing θ =0 .10 tends to do best, while θ =0 .05
is preferable under relatively ‘strong’ selection on unobservables.
In light of these recommendations, one might wonder why restricting the sample to an interval deter-
mined by estimates obtained from the BVN model, even when the BVN model is mis-speciﬁed and the
resulting estimates seem quite biased, yields an improvement over the Hirano and Imbens (2001) estimator.
Do our results indicate that restricting the estimation sample to observations with a propensity score lying
in some subset of the unit interval would improve on the ﬁnite sample performance of the Hirano and
Imbens (2001) estimator?
Tables 6-10 get at this question a bit. Speciﬁcally, we compare the results of our minimum biased
estimator obtained in Tables 1-5 with those obtained ﬁxing the BMPS, P∗, at its true value (i.e., the
optimal value using the values of ρ0uσ0 and ρδuσδ from the DGP).4 The results indicate three ﬁndings.
First, when the parametric assumptions are all valid (Table 6) or only the error distribution is mis-speciﬁed
(Table 9), there is little substantive diﬀerence in performance between using our estimated P∗ and the true
P∗. This is not surprising given our previous ﬁnding that b τBVN performs well in this two experiments.
Second, when both the outcome equation is mis-speciﬁed with or without the error distribution also being
mis-speciﬁed (Tables 7 and 10), the is a deﬁnite gain to knowing the true P∗. Note, this is a not an
indictment of our estimation procedure, but it does show that the performance of our estimator, albeit
better than the Hirano and Imbens (2001) estimator, can do even better with an improved estimate of
P∗. Finally, when both the propensity score equation and the outcome equation are mis-speciﬁed (Table
7), using the true P∗ does signiﬁcantly worse relative to using our estimated P∗.A s a r e s u l t , w h e n w e
4Note, when unconfoundness holds, P
∗ does not take on a unique value, but all values of P
∗ minimize the bias (and the
bias is zero). Thus, we focus only on the cases where unconfoundedness does not hold.
15are using poor estimates of the propensity score — because the equation is mis-speciﬁed — we are better oﬀ
choosing the estimation sample using the estimated P∗ based on the same mis-speciﬁed model, rather than
choosing the estimation sample using the true P∗ combined with the poorly estimated propensity scores.
In sum, then, our minimum biased estimator proves to be beneﬁcial when unconfoundedness holds,
but especially when it does not. Moreover, practitioners would be wise to assess the sensitivity of the
estimators to various values of θ. We now illustrate this approach with an application.
4 Application
4.1 Background
To illustrate the estimation approach advocated herein using actual data, we revisit the analysis of school
nutrition programs and childhood obesity in Millimet et al. (2008; hereafter MTH). As is quite evident
from recent media reports, childhood obesity is deemed to have reached epidemic status (see Rosin (2008)
for a review). In light of this, school nutrition programs, particularly the School Breakfast Program (SBP),
have garnered much interest. We are interested in the role of this program in the obesity crisis.
Since extensive institutional details are provided in MTH, we simply provide a brief sketch of the SBP
here. The SBP is federally funded, overseen by the US Department of Agriculture, administered by state
education agencies, and been in existence for several decades. Participation by schools — both public and
private — is voluntary (unless mandated by the state). If schools do participate, they are reimbursed a
ﬁxed amount per breakfast served. However, to qualify for reimbursement, the meals must meet federal
nutrition guidelines. Finally, students residing in households with family incomes at or below 130% of
the federal poverty line are eligible for free meals, while those in households with family incomes between
130% and 185% of the federal poverty line are entitled to reduced price meals. Schools are reimbursed at
a higher rate per free or reduced price meals served. Currently, about 10 million students eat breakfast at
school on any given day (covering about 80% of all schools).
Researchers interested in analyzing the causal eﬀect of participation in either program have been con-
cerned with the possible non-random selection of students into the program. MTH ﬁnd evidence of positive
selection on weight (in levels and growth rates) into the SBP (see also Bhattacharya et al. (2006)). In
light of the Monte Carlo results above, this suggests a lower value of θ is more appropriate when analyzing
the impact of participation in the SBP.
164.2 Data
The data are obtained from Early Childhood Longitudinal Study-Kindergarten Class of 1998-99 (ECLS-K)
and are identical to MTH; thus, we only provide limited details. We measure of participation in the SBP at
the earliest possible date, which is in spring kindergarten. Our outcomes of interest are measures of child
health in spring third grade or the change from fall kindergarten to spring third grade. As such, we are
analyzing more of the long-run relationship between child health and participation in these two programs.
Speciﬁcally, we utilize seven measures of child health:
(i) body mass index (BMI) in levels in spring third grade,
(ii) BMI in logs in spring third grade,
(iii) growth rate in BMI (i.e., change in log BMI) from fall kindergarten to spring third grade,
(iv) BMI in percentile in spring third grade,
(v) change in BMI percentile from fall kindergarten to spring third grade,
(vi) indicator for overweight status in spring third grade, and
(vii) indicator for obesity status in spring third grade,
where we deﬁne overweight (obesity) as having a BMI above the (85th)9 5 th percentile.5
To control for student, parental, and environmental factors, the following covariates are included in X:
child’s race (white, black, Hispanic, Asian, and other) and gender, child’s birthweight, household income,
mother’s employment status, mother’s education, number of children’s books at home, mother’s age at ﬁrst
birth, an indicator if the child’s mother received WIC beneﬁts during pregnancy, region, city type (urban,
suburban, or rural), and the amount of food in the household.6
Given the nature of our data, children with missing data for gender and race are dropped from our
sample. Missing values for the remaining control variables are imputed and imputation dummies are added
to the control set. The ﬁnal sample contains 13,534 students, of which 3,161 participate in the SBP. Table
11 provides summary statistics.
4.3 Results
The results are presented in Table 12. We report OLS estimates of the ATE in addition to the estimators
considered in the Monte Carlo study. Given the increa s ei ns a m p l es i z er e l a t i v et ot h eM o n t eC a r l os t u d y ,
5Percentiles are obtained using the -zanthro- command in Stata.
6Except for maternal employment, all controls come from either the fall or spring kindergarten survey.
17we also set θ =0 .01 and 0.03. In addition, we report the coeﬃcient estimates on the selection terms
included in the BVN model, as well as the corresponding BMPS, P∗, and bias obtained from (12). Finally,
all standard errors and 90% conﬁdence intervals are obtained using 500 bootstrap repetitions.7
T u r n i n gt oT a b l e1 2 ,t h r e eﬁndings stand out. First, consonant with MTH, there is evidence of selection
on unobservables. Speciﬁcally, \ ρ0uσ0 is positive and statistically signiﬁcant in ﬁve of the seven models.
While \ ρδuσδ is negative in six of the seven models, the estimates are never statistically signiﬁcant. Thus,
the evidence suggest that unobservables associated with higher weight in the untreated state are positively
correlated with treatment participation. However, there is no statistically meaningful evidence that children
select into the treatment on the basis of unobserved, individual-speciﬁce ﬀects of treatment.
Second, the estimated ATE is positive and statistically signiﬁcant across all outcomes when using b τHI
or b τOLS. However, in light of the BVN estimates discussed above, as well as the evidence provided in
MTH, it is unlikely that these estimators are unbiased. The BVN estimates of the ATEs, on the other
hand, are negative in ﬁve of seven models, although the estimates are very imprecise; the standard errors
are between 13 and 17 times larger than those for b τHI.
Finally, our minimum biased estimators yield estimates that are always statistically insigniﬁcant. This
arises for two reasons. First, given the evidence provided here and in MTH concerning selection on
unobservables, the point estimates when θ =0 .05, for example, are smaller than the corresponding Hirano
and Imbens (2001) estimator in ﬁve of seven cases. Moving to θ =0 .01, the point estimates become even
smaller, and are negative, in four of seven cases. Second, the standard errors when θ =0 .05 are roughly
two to three times larger than for b τHI; the standard errors are roughly twice as large when θ =0 .01 than
when θ =0 .05. Nonetheless, the fact that the point estimates diminish in the majority of cases as θ gets
smaller, and four are negative for the smallest value of θ, is consistent with our expectations and illustrates
the usefulness of our approach.
5C o n c l u s i o n
Black and Smith (2004) propose restricting the estimation sample to observations with propensity scores
around one-half when estimating the ATT under unconfoundedness, but the researcher is worried that this
assumption may not hold. In this study, we extend this argument to the case where the researcher may be
interested in other average treatment eﬀect parameters such as the ATU or ATE. This extension reveals
two interesting ﬁndings. First, under non-negative selection on individual-speciﬁc, unobserved gains to
treatment, the bias that results when unconfoundedness fails to hold is smallest when estimating the ATT.
7Conﬁd e n c ei n t e r v a l sa r eo b t a i n e du s i n gt h ep e r c e n t i l em e t h o d . A school-level clustered bootstrap was also utilized; the
conﬁdence intervals always included zero (results available upon request).
18Second, the value of the propensity score that minimizes the bias of estimators of the ATE is not ﬁxed,
but rather depends on the correlation structure of the unobservables in the underlying data-generating
process.
To operationalize this knowledge, we have proposed a new, two-stage estimation technique of the
ATE. In the ﬁrst-stage, one estimates the usual Heckman bivariate normal selection model in order to
recover estimates of the error correlation structure. These estimates are then used to obtain the value
of the propensity score that minimizes the bias of selection on observables estimators of the ATE when
unconfoundedness fails. In the second-stage, one estimates the ATE using only observations within a
neighborhood around this bias-minimizing value of the propensity score.
Simulated data reveals that our approach is extremely useful in certain situations, and thus provides
a nice addition to existing methods. Importantly, we show that our approach improves upon traditional
selection on observables estimators not only when unconfoundedness does not hold and the usual Heckman
bivariate normal selection model is mis-speciﬁed, but also when unconfoundedness holds. Future work
should consider how θ may be chosen optimally in some sense, how observations may be diﬀerentially
weighted depending on their proximity to the bias-minimizing propensity score, and how our method
performs when the eﬀect of treatment varies with observables.
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21Figure 1. Bias-Minimizing Value of the Propensity Score Under Diﬀerent Parameter Values
Assuming Positive Selection on Unobserved, Individual-Speciﬁc Gains into Treatment.
22Figure 2. Bias-Minimizing Value of the Propensity Score Under Diﬀerent Parameter Values
Assuming Negative Selection on Unobserved, Individual-Speciﬁc Gains into Treatment.
23Figure 3. Bias-Minimizing Value of the Propensity Score Under Diﬀerent Parameter Values.
Note: P∗ denotes the bias-minimizing value of the propensity score.
24Table 1.  Monte Carlo Results: All Parametric Assumptions Valid.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN ESTIMATE
  ρ0σ0 -0.006 0.248 0.496 0.005 -0.015 -0.003 0.145 0.140 0.137 0.308 0.301 0.301
  ρδσδ -0.004 0.262 0.503 0.004 0.258 0.510 -0.016 0.243 0.491
  α0.25 0.326 0.324 0.326 0.559 0.587 0.660 0.580 0.603 0.695 0.500 0.558 0.652
  α0.10 0.157 0.156 0.156 0.297 0.370 0.459 0.307 0.400 0.492 0.245 0.358 0.450
  α0.05 0.088 0.089 0.089 0.184 0.237 0.306 0.188 0.257 0.333 0.142 0.220 0.293
BIAS
  τBVN 0.005 0.011 0.010 -0.001 0.005 0.003 0.004 -0.001 0.010 0.005 0.002 0.009
  τHI 0.005 0.462 0.927 0.020 0.251 0.529 0.281 0.542 0.799 0.562 0.812 1.074
  τMB,0.25 -0.004 0.420 0.827 0.011 0.176 0.375 0.241 0.443 0.631 0.499 0.713 0.898
  τMB,0.10 -0.001 0.403 0.806 0.028 0.128 0.275 0.220 0.386 0.521 0.468 0.662 0.805
  τMB,0.05 -0.011 0.401 0.818 0.022 0.123 0.222 0.215 0.376 0.473 0.452 0.628 0.765
MAE
  τBVN 0.096 0.093 0.096 0.095 0.091 0.092 0.093 0.087 0.089 0.088 0.092 0.090
  τHI 0.170 0.463 0.927 0.158 0.273 0.529 0.295 0.542 0.799 0.562 0.812 1.074
  τMB,0.25 0.115 0.420 0.827 0.146 0.220 0.379 0.256 0.445 0.631 0.500 0.713 0.898
  τMB,0.10 0.151 0.405 0.806 0.169 0.219 0.309 0.257 0.402 0.525 0.470 0.663 0.806
  τMB,0.05 0.206 0.415 0.818 0.209 0.253 0.299 0.278 0.409 0.491 0.458 0.629 0.767
MSE
  τBVN 0.015 0.014 0.014 0.014 0.013 0.013 0.014 0.012 0.012 0.012 0.013 0.013
  τHI 0.045 0.244 0.884 0.038 0.101 0.312 0.114 0.327 0.669 0.343 0.686 1.178
  τMB,0.25 0.021 0.196 0.701 0.033 0.069 0.179 0.088 0.231 0.434 0.277 0.540 0.836
  τMB,0.10 0.036 0.200 0.682 0.045 0.073 0.136 0.093 0.206 0.334 0.256 0.486 0.700
  τMB,0.05 0.069 0.228 0.726 0.069 0.097 0.135 0.111 0.225 0.314 0.265 0.459 0.660
Notes: Results based on 500 simulated data sets, each containing 1000 observations.  MAE = mean absolute bias; MSE = mean squared error.  BVN = Heckman bivariate normal selection model; HI = Hirano and 
Imbens (2001) estimator; MB = minimum biased estimator using a cut-off level (α) chosen to retain 25%, 10%, or 5% of the treatment and control groups.  Shaded results indicate the best performance.  See text 
for further details.
Constant Treatment Effect Heterogeneous Treatment Effect
0 0.15 0.30Table 2.  Monte Carlo Results: Functional Form Mis-Specified for Outcome Equation.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN ESTIMATE
  ρ0σ0 -5.757 -5.513 -5.265 -6.223 -6.258 -6.313 -6.129 -6.109 -6.127 -5.957 -5.992 -5.948
  ρδσδ 0.844 1.118 1.456 0.924 1.127 1.413 0.874 1.172 1.408
  α0.25 0.326 0.324 0.326 0.381 0.394 0.425 0.388 0.398 0.425 0.380 0.404 0.433
  α0.10 0.157 0.156 0.156 0.142 0.137 0.139 0.142 0.138 0.138 0.139 0.138 0.140
  α0.05 0.088 0.089 0.089 0.076 0.071 0.069 0.076 0.072 0.069 0.074 0.071 0.069
BIAS
  τBVN 10.042 10.064 10.065 10.030 10.046 10.065 10.043 10.042 10.044 10.054 10.062 10.007
  τHI 0.005 0.462 0.927 0.020 0.251 0.529 0.281 0.542 0.799 0.562 0.812 1.074
  τMB,0.25 -0.004 0.419 0.827 -0.006 0.275 0.598 0.244 0.544 0.858 0.509 0.801 1.125
  τMB,0.10 -0.001 0.403 0.807 0.001 0.261 0.542 0.256 0.501 0.796 0.489 0.748 1.048
  τMB,0.05 -0.012 0.403 0.815 0.002 0.261 0.541 0.261 0.488 0.781 0.488 0.740 1.032
MAE
  τBVN 10.042 10.064 10.065 10.030 10.046 10.065 10.043 10.042 10.044 10.054 10.062 10.007
  τHI 0.170 0.463 0.927 0.158 0.273 0.529 0.295 0.542 0.799 0.562 0.812 1.074
  τMB,0.25 0.115 0.420 0.827 0.130 0.280 0.598 0.256 0.544 0.858 0.509 0.801 1.125
  τMB,0.10 0.151 0.405 0.807 0.159 0.277 0.542 0.270 0.502 0.796 0.489 0.748 1.048
  τMB,0.05 0.205 0.416 0.815 0.221 0.296 0.544 0.299 0.492 0.781 0.491 0.740 1.032
MSE
  τBVN 101.017 101.452 101.475 100.782 101.119 101.474 101.029 101.012 101.051 101.255 101.418 100.302
  τHI 0.045 0.244 0.884 0.038 0.101 0.312 0.114 0.327 0.669 0.343 0.686 1.178
  τMB,0.25 0.021 0.196 0.702 0.027 0.104 0.384 0.086 0.323 0.761 0.281 0.664 1.285
  τMB,0.10 0.037 0.200 0.684 0.039 0.105 0.327 0.098 0.285 0.667 0.270 0.594 1.122
  τMB,0.05 0.068 0.229 0.721 0.074 0.131 0.352 0.131 0.292 0.668 0.295 0.605 1.109
Notes: See Table 1.
0 0.15 0.30
Constant Treatment Effect Heterogeneous Treatment EffectTable 3.  Monte Carlo Results: Functional Form Mis-Specified for Propensity Score Equation and Outcome Equation.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN ESTIMATE
  ρ0σ0 85.170 84.426 82.129 123.228 119.039 118.633 121.819 120.524 119.603 120.478 119.015 116.419
  ρδσδ -16.884 -16.443 -16.328 -16.907 -16.619 -16.482 -16.524 -16.700 -16.203
  α0.25 0.073 0.074 0.073 0.121 0.122 0.121 0.122 0.121 0.121 0.121 0.122 0.123
  α0.10 0.033 0.034 0.034 0.072 0.072 0.072 0.073 0.072 0.072 0.071 0.073 0.072
  α0.05 0.020 0.020 0.020 0.045 0.045 0.044 0.045 0.045 0.045 0.044 0.045 0.045
BIAS
  τBVN -132.212 -130.875 -127.001 -178.939 -172.468 -171.819 -176.506 -174.594 -173.124 -174.625 -171.991 -168.184
  τHI 7.619 7.757 7.902 7.641 7.702 7.784 7.739 7.763 7.826 7.775 7.852 7.934
  τMB,0.25 3.649 3.892 4.103 3.235 3.429 3.605 3.405 3.561 3.773 3.519 3.759 3.929
  τMB,0.10 3.117 3.362 3.637 2.582 2.868 3.115 2.778 3.030 3.326 2.964 3.278 3.524
  τMB,0.05 2.983 3.265 3.520 2.404 2.717 3.019 2.617 2.905 3.250 2.818 3.183 3.440
MAE
  τBVN 132.212 130.875 127.001 178.939 172.468 171.819 176.506 174.594 173.124 174.625 171.991 168.184
  τHI 7.619 7.757 7.902 7.641 7.702 7.784 7.739 7.763 7.826 7.775 7.852 7.934
  τMB,0.25 3.649 3.892 4.103 3.235 3.429 3.605 3.405 3.561 3.773 3.519 3.759 3.929
  τMB,0.10 3.117 3.362 3.637 2.582 2.868 3.115 2.778 3.030 3.326 2.964 3.278 3.524
  τMB,0.05 2.983 3.265 3.520 2.404 2.717 3.019 2.617 2.905 3.250 2.818 3.183 3.440
MSE
  τBVN 1.9E+04 1.9E+04 1.7E+04 3.4E+04 3.2E+04 3.2E+04 3.4E+04 3.3E+04 3.2E+04 3.2E+04 3.2E+04 3.0E+04
  τHI 58.219 60.320 62.606 58.561 59.474 60.760 60.060 60.404 61.390 60.623 61.800 63.099
  τMB,0.25 13.521 15.380 17.054 10.586 11.890 13.127 11.705 12.811 14.358 12.495 14.231 15.545
  τMB,0.10 10.085 11.679 13.616 6.840 8.417 9.895 7.881 9.362 11.244 8.951 10.886 12.566
  τMB,0.05 9.421 11.232 12.959 6.000 7.628 9.355 7.062 8.677 10.824 8.156 10.324 12.020
Notes: See Table 1.
Constant Treatment Effect Heterogeneous Treatment Effect
0 0.15 0.30Table 4.  Monte Carlo Results: Error Distribution is Mis-specified.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN ESTIMATE
  ρ0σ0 -0.004 0.142 0.283 0.009 -0.007 0.006 0.084 0.078 0.079 0.172 0.172 0.176
  ρδσδ -0.008 0.149 0.277 0.006 0.147 0.288 -0.009 0.136 0.272
  α0.25 0.482 0.471 0.479 0.728 0.734 0.796 0.731 0.745 0.825 0.684 0.701 0.785
  α0.10 0.249 0.249 0.248 0.401 0.474 0.564 0.412 0.502 0.597 0.367 0.462 0.555
  α0.05 0.145 0.144 0.145 0.225 0.294 0.370 0.230 0.314 0.397 0.197 0.287 0.358
BIAS
  τBVN 0.002 0.008 0.010 -0.001 0.003 0.003 0.002 0.003 0.010 0.007 0.005 0.011
  τHI 0.071 0.331 0.576 0.086 0.216 0.378 0.226 0.366 0.507 0.374 0.513 0.663
  τMB,0.25 -0.040 0.226 0.482 0.015 0.130 0.271 0.159 0.273 0.404 0.305 0.423 0.570
  τMB,0.10 -0.038 0.207 0.456 0.037 0.125 0.242 0.157 0.253 0.359 0.292 0.408 0.530
  τMB,0.05 -0.023 0.223 0.477 0.050 0.128 0.236 0.150 0.254 0.353 0.283 0.402 0.522
MAE
  τBVN 0.049 0.048 0.051 0.049 0.046 0.047 0.047 0.045 0.045 0.045 0.046 0.047
  τHI 0.103 0.332 0.576 0.107 0.219 0.378 0.227 0.366 0.507 0.374 0.513 0.663
  τMB,0.25 0.102 0.228 0.482 0.082 0.138 0.271 0.165 0.273 0.404 0.305 0.423 0.570
  τMB,0.10 0.102 0.212 0.456 0.105 0.152 0.245 0.172 0.255 0.359 0.292 0.408 0.530
  τMB,0.05 0.127 0.232 0.477 0.132 0.165 0.247 0.177 0.261 0.355 0.285 0.403 0.522
MSE
  τBVN 0.004 0.004 0.004 0.004 0.003 0.004 0.004 0.003 0.003 0.003 0.003 0.003
  τHI 0.016 0.118 0.339 0.017 0.057 0.151 0.061 0.142 0.265 0.148 0.271 0.446
  τMB,0.25 0.016 0.062 0.242 0.010 0.026 0.082 0.036 0.083 0.172 0.102 0.189 0.332
  τMB,0.10 0.016 0.057 0.219 0.017 0.033 0.075 0.041 0.081 0.146 0.098 0.182 0.295
  τMB,0.05 0.025 0.074 0.247 0.026 0.041 0.082 0.046 0.089 0.149 0.101 0.183 0.291
Notes: See Table 1.
Constant Treatment Effect Heterogeneous Treatment Effect
0 0.15 0.30Table 5.  Monte Carlo Results: Functional Form Mis-Specified for Outcome Equation and Error Distribution.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN ESTIMATE
  ρ0σ0 -5.053 -4.915 -4.778 -5.576 -5.612 -5.658 -5.536 -5.520 -5.514 -5.448 -5.461 -5.439
  ρδσδ 0.907 1.097 1.303 0.981 1.095 1.223 0.975 1.130 1.255
  α0.25 0.482 0.471 0.479 0.571 0.585 0.610 0.587 0.593 0.602 0.581 0.592 0.612
  α0.10 0.249 0.249 0.248 0.230 0.228 0.232 0.234 0.230 0.229 0.230 0.231 0.231
  α0.05 0.145 0.144 0.145 0.126 0.123 0.121 0.128 0.124 0.120 0.127 0.124 0.119
BIAS
  τBVN 8.886 8.905 8.915 8.896 8.899 8.920 8.900 8.885 8.898 8.893 8.908 8.888
  τHI 0.071 0.331 0.576 0.086 0.216 0.378 0.226 0.366 0.507 0.374 0.513 0.663
  τMB,0.25 -0.040 0.227 0.483 0.030 0.173 0.342 0.182 0.321 0.479 0.325 0.476 0.632
  τMB,0.10 -0.039 0.207 0.456 -0.028 0.138 0.317 0.124 0.281 0.466 0.267 0.438 0.617
  τMB,0.05 -0.023 0.224 0.477 -0.010 0.135 0.293 0.142 0.269 0.440 0.270 0.424 0.597
MAE
  τBVN 8.886 8.905 8.915 8.896 8.899 8.920 8.900 8.885 8.898 8.893 8.908 8.888
  τHI 0.103 0.332 0.576 0.107 0.219 0.378 0.227 0.366 0.507 0.374 0.513 0.663
  τMB,0.25 0.102 0.229 0.483 0.083 0.177 0.342 0.186 0.321 0.479 0.326 0.476 0.632
  τMB,0.10 0.102 0.211 0.456 0.103 0.156 0.317 0.143 0.282 0.466 0.267 0.438 0.617
  τMB,0.05 0.126 0.233 0.477 0.131 0.168 0.297 0.171 0.274 0.440 0.273 0.424 0.597
MSE
  τBVN 79.095 79.429 79.615 79.271 79.331 79.700 79.346 79.072 79.288 79.216 79.482 79.134
  τHI 0.016 0.118 0.339 0.017 0.057 0.151 0.061 0.142 0.265 0.148 0.271 0.446
  τMB,0.25 0.016 0.063 0.242 0.011 0.040 0.125 0.043 0.112 0.238 0.115 0.235 0.405
  τMB,0.10 0.016 0.057 0.219 0.016 0.035 0.114 0.028 0.093 0.229 0.084 0.204 0.389
  τMB,0.05 0.025 0.074 0.247 0.026 0.043 0.109 0.043 0.096 0.212 0.092 0.199 0.369
Notes: See Table 1.
Constant Treatment Effect Heterogeneous Treatment Effect
0 0.15 0.30Table 6.  Monte Carlo Results: Comparison of Using True P
* vs. Estimated P* When All Parametric Assumptions 
                    are Valid.   
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN
  Estimated P
* 0.499 0.499 0.499 0.508 0.730 0.876 0.491 0.803 0.912 0.482 0.763 0.866
  True P
* 0.498 0.498 0.980 0.980 0.498 0.886 0.947 0.498 0.793 0.886
BIAS (Estimated P*)
  τMB,0.25 -0.004 0.420 0.827 0.011 0.176 0.375 0.241 0.443 0.631 0.499 0.713 0.898
  τMB,0.10 -0.001 0.403 0.806 0.028 0.128 0.275 0.220 0.386 0.521 0.468 0.662 0.805
  τMB,0.05 -0.011 0.401 0.818 0.022 0.123 0.222 0.215 0.376 0.473 0.452 0.628 0.765
BIAS (True P*)
  τMB,0.25 0.419 0.827 0.171 0.374 0.250 0.447 0.630 0.489 0.720 0.901
  τMB,0.10 0.403 0.807 0.115 0.269 0.248 0.400 0.522 0.488 0.686 0.809
  τMB,0.05 0.402 0.817 0.094 0.210 0.235 0.394 0.477 0.478 0.678 0.779
MAE (Estimated P*)
  τMB,0.25 0.115 0.420 0.827 0.146 0.220 0.379 0.256 0.445 0.631 0.500 0.713 0.898
  τMB,0.10 0.151 0.405 0.806 0.169 0.219 0.309 0.257 0.402 0.525 0.470 0.663 0.806
  τMB,0.05 0.206 0.415 0.818 0.209 0.253 0.299 0.278 0.409 0.491 0.458 0.629 0.767
MAE (True P*)
  τMB,0.25 0.420 0.827 0.227 0.379 0.255 0.450 0.630 0.489 0.720 0.901
  τMB,0.10 0.405 0.807 0.241 0.311 0.266 0.418 0.526 0.488 0.687 0.809
  τMB,0.05 0.415 0.817 0.274 0.302 0.282 0.433 0.495 0.483 0.679 0.781
MSE (Estimated P*)
  τMB,0.25 0.021 0.196 0.701 0.033 0.069 0.179 0.088 0.231 0.434 0.277 0.540 0.836
  τMB,0.10 0.036 0.200 0.682 0.045 0.073 0.136 0.093 0.206 0.334 0.256 0.486 0.700
  τMB,0.05 0.069 0.228 0.726 0.069 0.097 0.135 0.111 0.225 0.314 0.265 0.459 0.660
MSE (True P*)
  τMB,0.25 0.196 0.702 0.073 0.178 0.083 0.238 0.434 0.258 0.551 0.841
  τMB,0.10 0.199 0.685 0.086 0.137 0.097 0.225 0.336 0.273 0.526 0.708
  τMB,0.05 0.229 0.727 0.111 0.137 0.123 0.248 0.321 0.286 0.535 0.691
Notes: Results using estimated correlation structure are replicated from Table 1.  Results using true P* utilize the P* corresponding to the true values of ρ 0σ0 and 
ρδσδ.  Shaded area indicates best overall performance.  True P* results are omitted under unconfoundedness since there is no unique value of P*.  For further




0.15 0.30 0Table 7.  Monte Carlo Results: Comparison of Using True P
* vs. Estimated P* When the Functional Form
                    Is Mis-Specified for the Outcome Equation.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN
  Estimated P
* 0.499 0.499 0.499 0.418 0.390 0.356 0.408 0.387 0.356 0.411 0.379 0.352
  True P
* 0.498 0.498 0.980 0.980 0.498 0.886 0.947 0.498 0.793 0.886
BIAS (Estimated P*)
  τMB,0.25 -0.004 0.419 0.827 -0.006 0.275 0.598 0.244 0.544 0.858 0.509 0.801 1.125
  τMB,0.10 -0.001 0.403 0.807 0.001 0.261 0.542 0.256 0.501 0.796 0.489 0.748 1.048
  τMB,0.05 -0.012 0.403 0.815 0.002 0.261 0.541 0.261 0.488 0.781 0.488 0.740 1.032
BIAS (True P*)
  τMB,0.25 0.419 0.827 0.171 0.374 0.250 0.447 0.630 0.489 0.720 0.901
  τMB,0.10 0.403 0.807 0.115 0.269 0.248 0.400 0.522 0.488 0.686 0.809
  τMB,0.05 0.402 0.817 0.094 0.210 0.235 0.394 0.477 0.478 0.678 0.779
MAE (Estimated P*)
  τMB,0.25 0.115 0.420 0.827 0.130 0.280 0.598 0.256 0.544 0.858 0.509 0.801 1.125
  τMB,0.10 0.151 0.405 0.807 0.159 0.277 0.542 0.270 0.502 0.796 0.489 0.748 1.048
  τMB,0.05 0.205 0.416 0.815 0.221 0.296 0.544 0.299 0.492 0.781 0.491 0.740 1.032
MAE (True P*)
  τMB,0.25 0.420 0.827 0.227 0.379 0.255 0.450 0.630 0.489 0.720 0.901
  τMB,0.10 0.405 0.807 0.241 0.311 0.266 0.418 0.526 0.488 0.687 0.809
  τMB,0.05 0.415 0.817 0.274 0.302 0.282 0.433 0.495 0.483 0.679 0.781
MSE (Estimated P*)
  τMB,0.25 0.021 0.196 0.702 0.027 0.104 0.384 0.086 0.323 0.761 0.281 0.664 1.285
  τMB,0.10 0.037 0.200 0.684 0.039 0.105 0.327 0.098 0.285 0.667 0.270 0.594 1.122
  τMB,0.05 0.068 0.229 0.721 0.074 0.131 0.352 0.131 0.292 0.668 0.295 0.605 1.109
MSE (True P*)
  τMB,0.25 0.196 0.702 0.073 0.178 0.083 0.238 0.434 0.258 0.551 0.841
  τMB,0.10 0.199 0.685 0.086 0.137 0.097 0.225 0.336 0.273 0.526 0.708
  τMB,0.05 0.229 0.727 0.111 0.137 0.123 0.248 0.321 0.286 0.535 0.691
Notes: Results using estimated correlation structure are replicated from Table 2.  For further details, see Table 6.
Constant Treatment Heterogeneous Treatment Effect
Effect
0 0.15 0.30Table 8.  Monte Carlo Results: Comparison of Using True P
* vs. Estimated P* When the Functional Form
                    is Mis-Specified for the Propensity Score Equation and Outcome Equation.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN
  Estimated P
* 0.499 0.499 0.499 0.413 0.412 0.413 0.411 0.413 0.413 0.413 0.411 0.412
  True P
* 0.498 0.498 0.980 0.980 0.498 0.886 0.947 0.498 0.793 0.886
BIAS (Estimated P*)
  τMB,0.25 3.649 3.892 4.103 3.235 3.429 3.605 3.405 3.561 3.773 3.519 3.759 3.929
  τMB,0.10 3.117 3.362 3.637 2.582 2.868 3.115 2.778 3.030 3.326 2.964 3.278 3.524
  τMB,0.05 2.983 3.265 3.520 2.404 2.717 3.019 2.617 2.905 3.250 2.818 3.183 3.440
BIAS (True P*)
  τMB,0.25 3.881 4.095 8.512 8.591 3.801 8.584 8.635 3.896 8.654 8.696
  τMB,0.10 3.348 3.621 11.111 11.182 3.286 11.176 11.183 3.422 11.165 11.162
  τMB,0.05 3.250 3.510 13.573 13.667 3.182 13.627 13.595 3.300 13.582 13.546
MAE (Estimated P*)
  τMB,0.25 3.649 3.892 4.103 3.235 3.429 3.605 3.405 3.561 3.773 3.519 3.759 3.929
  τMB,0.10 3.117 3.362 3.637 2.582 2.868 3.115 2.778 3.030 3.326 2.964 3.278 3.524
  τMB,0.05 2.983 3.265 3.520 2.404 2.717 3.019 2.617 2.905 3.250 2.818 3.183 3.440
MAE (True P*)
  τMB,0.25 3.881 4.095 8.512 8.591 3.801 8.584 8.635 3.896 8.654 8.696
  τMB,0.10 3.348 3.621 11.111 11.182 3.286 11.176 11.183 3.422 11.165 11.162
  τMB,0.05 3.250 3.510 13.573 13.667 3.182 13.627 13.595 3.300 13.582 13.546
MSE (Estimated P*)
  τMB,0.25 13.521 15.380 17.054 10.586 11.890 13.127 11.705 12.811 14.358 12.495 14.231 15.545
  τMB,0.10 10.085 11.679 13.616 6.840 8.417 9.895 7.881 9.362 11.244 8.951 10.886 12.566
  τMB,0.05 9.421 11.232 12.959 6.000 7.628 9.355 7.062 8.677 10.824 8.156 10.324 12.020
MSE (True P*)
  τMB,0.25 15.289 16.988 72.714 74.101 14.669 73.935 74.819 15.388 75.142 75.857
  τMB,0.10 11.580 13.501 124.571 126.405 11.201 126.023 126.321 12.098 125.815 125.639
  τMB,0.05 11.122 12.892 186.986 189.832 10.703 188.494 187.667 11.398 187.006 185.870
Notes: Results using estimated correlation structure are replicated from Table 3.  For further details, see Table 6.
Constant Treatment Heterogeneous Treatment Effect
Effect
0 0.15 0.30Table 9.  Monte Carlo Results: Comparison of Using True P
* vs. Estimated P* When the Error Distribution 
                         Is Mis-Specified.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN
  Estimated P
* 0.499 0.499 0.499 0.475 0.718 0.867 0.498 0.779 0.899 0.480 0.749 0.856
  True P
* 0.498 0.498 0.980 0.980 0.498 0.886 0.947 0.498 0.793 0.886
BIAS (Estimated P*)
  τMB,0.25 -0.040 0.226 0.482 0.015 0.130 0.271 0.159 0.273 0.404 0.305 0.423 0.570
  τMB,0.10 -0.038 0.207 0.456 0.037 0.125 0.242 0.157 0.253 0.359 0.292 0.408 0.530
  τMB,0.05 -0.023 0.223 0.477 0.050 0.128 0.236 0.150 0.254 0.353 0.283 0.402 0.522
BIAS (True P*)
  τMB,0.25 0.228 0.484 0.115 0.269 0.131 0.271 0.404 0.275 0.422 0.570
  τMB,0.10 0.207 0.456 0.127 0.243 0.109 0.272 0.360 0.258 0.428 0.534
  τMB,0.05 0.224 0.477 0.151 0.243 0.130 0.303 0.359 0.268 0.449 0.534
MAE (Estimated P*)
  τMB,0.25 0.102 0.228 0.482 0.082 0.138 0.271 0.165 0.273 0.404 0.305 0.423 0.570
  τMB,0.10 0.102 0.212 0.456 0.105 0.152 0.245 0.172 0.255 0.359 0.292 0.408 0.530
  τMB,0.05 0.127 0.232 0.477 0.132 0.165 0.247 0.177 0.261 0.355 0.285 0.403 0.522
MAE (True P*)
  τMB,0.25 0.230 0.484 0.133 0.270 0.145 0.271 0.404 0.275 0.422 0.570
  τMB,0.10 0.212 0.456 0.159 0.249 0.136 0.274 0.361 0.260 0.429 0.534
  τMB,0.05 0.233 0.477 0.188 0.255 0.160 0.307 0.361 0.272 0.450 0.534
MSE (Estimated P*)
  τMB,0.25 0.016 0.062 0.242 0.010 0.026 0.082 0.036 0.083 0.172 0.102 0.189 0.332
  τMB,0.10 0.016 0.057 0.219 0.017 0.033 0.075 0.041 0.081 0.146 0.098 0.182 0.295
  τMB,0.05 0.025 0.074 0.247 0.026 0.041 0.082 0.046 0.089 0.149 0.101 0.183 0.291
MSE (True P*)
  τMB,0.25 0.063 0.243 0.025 0.082 0.030 0.083 0.172 0.087 0.187 0.332
  τMB,0.10 0.057 0.219 0.037 0.076 0.027 0.093 0.147 0.080 0.201 0.300
  τMB,0.05 0.074 0.247 0.050 0.085 0.040 0.119 0.155 0.096 0.226 0.307
Notes: Results using estimated correlation structure are replicated from Table 4.  For further details, see Table 6.
Constant Treatment Heterogeneous Treatment Effect
Effect
0 0.15 0.30Table 10.  Monte Carlo Results: Comparison of Using True P
* vs. Estimated P* When the Functional Form 
                    Is Mis-Specified for the Outcome Equation and Error Distribution.
True ρ0σ0 = 0 0.25 0.50
True ρδσδ = 0 0.25 0.50 0 0.25 0.50 0 0.25 0.50
MEAN
  Estimated P
* 0.499 0.498 0.498 0.401 0.379 0.357 0.391 0.378 0.362 0.390 0.372 0.356
  True P
* 0.498 0.498 0.980 0.980 0.498 0.886 0.947 0.498 0.793 0.886
BIAS (Estimated P*)
  τMB,0.25 -0.040 0.227 0.483 0.030 0.173 0.342 0.182 0.321 0.479 0.325 0.476 0.632
  τMB,0.10 -0.039 0.207 0.456 -0.028 0.138 0.317 0.124 0.281 0.466 0.267 0.438 0.617
  τMB,0.05 -0.023 0.224 0.477 -0.010 0.135 0.293 0.142 0.269 0.440 0.270 0.424 0.597
BIAS (True P*)
  τMB,0.25 0.228 0.484 0.115 0.269 0.131 0.271 0.404 0.275 0.422 0.570
  τMB,0.10 0.207 0.456 0.127 0.243 0.109 0.272 0.360 0.258 0.428 0.534
  τMB,0.05 0.224 0.477 0.151 0.243 0.130 0.303 0.359 0.268 0.449 0.534
MAE (Estimated P*)
  τMB,0.25 0.102 0.229 0.483 0.083 0.177 0.342 0.186 0.321 0.479 0.326 0.476 0.632
  τMB,0.10 0.102 0.211 0.456 0.103 0.156 0.317 0.143 0.282 0.466 0.267 0.438 0.617
  τMB,0.05 0.126 0.233 0.477 0.131 0.168 0.297 0.171 0.274 0.440 0.273 0.424 0.597
MAE (True P*)
  τMB,0.25 0.230 0.484 0.133 0.270 0.145 0.271 0.404 0.275 0.422 0.570
  τMB,0.10 0.212 0.456 0.159 0.249 0.136 0.274 0.361 0.260 0.429 0.534
  τMB,0.05 0.233 0.477 0.188 0.255 0.160 0.307 0.361 0.272 0.450 0.534
MSE (Estimated P*)
  τMB,0.25 0.016 0.063 0.242 0.011 0.040 0.125 0.043 0.112 0.238 0.115 0.235 0.405
  τMB,0.10 0.016 0.057 0.219 0.016 0.035 0.114 0.028 0.093 0.229 0.084 0.204 0.389
  τMB,0.05 0.025 0.074 0.247 0.026 0.043 0.109 0.043 0.096 0.212 0.092 0.199 0.369
MSE (True P*)
  τMB,0.25 0.063 0.243 0.025 0.082 0.030 0.083 0.172 0.087 0.187 0.332
  τMB,0.10 0.057 0.219 0.037 0.076 0.027 0.093 0.147 0.080 0.201 0.300
  τMB,0.05 0.074 0.247 0.050 0.085 0.040 0.119 0.155 0.096 0.226 0.307
Notes: Results using estimated correlation structure are replicated from Table 5.  For further details, see Table 6.
Constant Treatment Heterogeneous Treatment Effect
Effect
0 0.15 0.30Table 11.  Summary Statistics
Variable Mean SD Mean SD Mean SD
SBP Participation (1 = Yes) 0.234 0.423 1000
Third Grade Child Weight
   BMI 18.404 3.861 18.956 4.296 18.236 3.702
   BMI Growth Rate 0.112 0.126 0.128 0.137 0.107 0.122
   BMI percentile 62.326 30.105 65.662 29.794 61.309 30.128
   Change in BMI Percentile 1.295 22.887 2.894 23.108 0.808 22.798
   Overweight (1 = Yes) 0.325 0.468 0.368 0.482 0.312 0.463
   Obese (1 = Yes) 0.171 0.377 0.208 0.406 0.160 0.367
Controls
Age (in months) 110.767 4.356 110.869 4.389 110.737 4.346
Gender (1 = boy) 0.507 0.500 0.523 0.500 0.503 0.500
White (1 = Yes) 0.579 0.494 0.322 0.467 0.657 0.475
Black (1 = Yes) 0.138 0.345 0.312 0.463 0.085 0.279
Hispanic (1 = Yes) 0.174 0.379 0.239 0.427 0.154 0.361
Asian (1 = Yes) 0.054 0.226 0.042 0.200 0.057 0.233
Child's Birthweight (ounces) 118.284 20.040 115.806 21.452 119.039 19.529
Child's Birthweight (1 = Missing) 0.121 0.326 0.164 0.371 0.107 0.309
Central City (1 = Yes) 0.395 0.489 0.416 0.493 0.389 0.488
Urban Fringe & Large Town (1 = Yes) 0.377 0.485 0.259 0.438 0.413 0.492
Northeast (1 = Yes) 0.182 0.386 0.115 0.319 0.202 0.402
Midwest (1 = Yes) 0.250 0.433 0.194 0.395 0.268 0.443
South (1 = Yes) 0.346 0.476 0.508 0.500 0.297 0.457
Mother's Age at First Birth ≤ 19 Years  0.227 0.419 0.404 0.491 0.173 0.378
  Old (1 = Yes)
Mother's Age at First Birth is 20-29  0.522 0.500 0.410 0.492 0.556 0.497
  Years Old (1 = Yes)
Mother's Age at First Birth (1 = Missing) 0.104 0.305 0.140 0.347 0.093 0.290
WIC Benefits During Pregnancy (1 = Yes) 0.339 0.473 0.620 0.485 0.253 0.435
WIC Benefits During Pregnancy (1 = Missing) 0.112 0.315 0.140 0.347 0.103 0.304
Mother's Education = High School (1 = Yes) 0.198 0.398 0.243 0.429 0.184 0.387
Mother's Education = Some College (1 = Yes) 0.281 0.450 0.227 0.419 0.298 0.457
Mother's Education = Bachelor's  0.144 0.351 0.040 0.196 0.176 0.381
  Degree (1 = Yes)
Mother's Education = Advanced College  0.084 0.277 0.024 0.152 0.102 0.303
  Degree (1 = Yes)
Mother's Education (1 = Missing) 0.209 0.407 0.285 0.452 0.186 0.389
Household Income (dollars) 52150 32034 34535 21588 57518 32765
Mother Employed During 3rd Grade (1 = Yes) 0.572 0.495 0.467 0.499 0.604 0.489
Mother Employed During 3rd Grade (1 = No) 0.204 0.403 0.230 0.421 0.197 0.397
Sufficient Food of Type Desired in  0.847 0.360 0.736 0.441 0.881 0.324
  Household (1 = Yes)
Sufficient Food, but not of Type Desired  0.138 0.345 0.229 0.420 0.111 0.314
  in Household (1 = Yes)
Sufficient Food (1 = Missing) 0.001 0.028 0.002 0.040 0.001 0.024
NSLP Participation (1 = Yes) 0.575 0.494 0.894 0.308 0.477 0.500
Number of Children's Books in Household 74.930 57.030 48.638 46.803 82.942 57.457
Number of Children's Books in Household 0.097 0.296 0.119 0.323 0.091 0.287
   (1 = Missing)
Notes: N = 13,534 (full sample); 3,161 (SBP participants); 10,373 (SBP non-participants).  Data are from spring third grade wave of ECLS-K.   Change in 
BMI percentile and BMI growth rate calculated using baseline data from fall kindergarten.  Omitted category for race is 'other', city type is 'small town & 
rural', mother's age at first birth is greater than 29 years old, mother's employment is 'missing', mother's education is 'less than high school', and sufficient




Full SBPTable 12.  Estimates of Effect of SBP Participation 
BMI ln(BMI) BMI Percentile Change in Pr(Overweight) Pr(Obese)
Growth BMI Percentile BMI
τOLS 0.645 0.031 0.015 3.649 1.618 0.051 0.056
(0.149) (0.007) (0.004) (0.984) (0.799) (0.016) (0.014)
 [  0.400,   0.900]  [  0.019,   0.042]  [  0.008,   0.023]  [  1.910,   5.245]  [  0.375,   2.972]  [  0.024,   0.077]  [  0.034,   0.079]
τBVN 1.425 0.041 -0.022 -2.472 -9.021 -0.053 -0.088
(2.080) (0.104) (0.061) (14.002) (10.603) (0.235) (0.202)
 [ -2.007,   4.351]  [ -0.142,   0.205]  [ -0.117,   0.085]  [-25.935,  19.667]  [-27.182,   7.817]  [ -0.434,   0.327]  [ -0.416,   0.237]
τHI 0.392 0.019 0.013 2.574 2.016 0.033 0.029
(0.131) (0.006) (0.004) (1.008) (0.842) (0.016) (0.013)
 [  0.161,   0.596]  [  0.008,   0.030]  [  0.006,   0.019]  [  0.849,   4.148]  [  0.436,   3.279]  [  0.006,   0.057]  [  0.008,   0.052]
τMB,0.25 0.288 0.019 0.010 2.694 0.603 0.063 0.008
(0.165) (0.008) (0.005) (1.175) (0.775) (0.023) (0.020)
 [  0.075,   0.594]  [  0.003,   0.031]  [  0.002,   0.019]  [  0.509,   4.276]  [ -0.446,   1.990]  [ -0.009,   0.068]  [ -0.013,   0.055]
τMB,0.10 -0.007 0.025 0.003 2.887 0.873 0.074 -0.005
(0.239) (0.012) (0.007) (1.746) (1.131) (0.031) (0.028)
 [ -0.098,   0.725]  [ -0.004,   0.036]  [ -0.001,   0.023]  [ -0.567,   5.053]  [ -0.907,   2.654]  [ -0.025,   0.076]  [ -0.023,   0.069]
τMB,0.05 -0.017 0.013 -0.007 3.657 1.474 0.061 -0.007
(0.331) (0.017) (0.010) (2.554) (1.589) (0.041) (0.033)
 [ -0.212,   0.929]  [ -0.012,   0.047]  [ -0.005,   0.028]  [ -1.918,   6.832]  [ -1.375,   3.616]  [ -0.037,   0.093]  [ -0.032,   0.078]
τMB,0.03 0.138 0.014 -0.013 2.654 0.532 0.078 -0.029
(0.446) (0.022) (0.013) (2.843) (1.962) (0.047) (0.045)
 [ -0.368,   1.099]  [ -0.021,   0.053]  [ -0.008,   0.033]  [ -2.123,   6.800]  [ -1.992,   4.027]  [ -0.056,   0.097]  [ -0.052,   0.098]
τMB,0.01 -0.413 -0.024 0.014 7.601 -1.996 0.113 -0.104
(0.724) (0.035) (0.021) (5.064) (3.619) (0.074) (0.064)
 [ -0.921,   1.516]  [ -0.038,   0.079]  [ -0.018,   0.050]  [ -5.504,  10.067]  [ -5.896,   5.839]  [ -0.095,   0.150]  [ -0.076,   0.128]
ρ0σ0 0.901 0.044 0.021 5.367 0.771 0.084 0.079
(0.380) (0.018) (0.013) (3.171) (2.108) (0.048) (0.036)
 [  0.303,   1.536]  [  0.014,   0.075]  [ -0.000,   0.043]  [  0.418,  10.691]  [ -2.699,   4.054]  [  0.012,   0.164]  [  0.017,   0.137]
ρδσδ -1.604 -0.061 -0.003 -2.759 5.765 -0.038 -0.006
(1.338) (0.069) (0.041) (9.784) (7.128) (0.156) (0.131)
 [ -3.646,   0.772]  [ -0.168,   0.058]  [ -0.075,   0.064]  [-18.844,  14.201]  [ -5.756,  17.586]  [ -0.281,   0.222]  [ -0.209,   0.203]
P* 0.438 0.276 0.419 0.172 0.980 0.207 0.450
(0.261) (0.265) (0.315) (0.315) (0.240) (0.311) (0.306)
 [  0.041,   0.886]  [  0.037,   0.904]  [  0.042,   0.978]  [  0.031,   0.978]  [  0.237,   0.980]  [  0.032,   0.973]  [  0.028,   0.960]
Bias(P*) -0.001 0.000 0.031 5.517 2.191 0.093 0.120
(0.649) (0.037) (0.024) (5.221) (3.062) (0.090) (0.084)
 [ -0.005,   1.741]  [ -0.000,   0.101]  [ -0.000,   0.067]  [ -0.031,  15.368]  [ -0.497,   8.139]  [ -0.000,   0.259]  [ -0.000,   0.239]
Notes: Treatment is defined as participation in SBP.  Standard errors in parenthesis and 90% empirical confidence intervals obtained using 500 bootstrap repetitions.  OLS = ordinary least
squares; BVN = Heckman bivariate normal selection model; HI = Hirano and Imbens (2001) normalized estimator; MB = minimum biased estimator using θ = 0.25, 0.10, 0.05, 0.03, or 0.01.